Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD. (Q53043334)

10 May 2018

title

Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD. (English)

1 reference

10 May 2018

cost-effectiveness analysis

main subject

1 reference

based on heuristic

inferred from title

eosinophilic esophagitis

1 reference

Stephen M Miller

1

1 reference

10 May 2018

Jay L Goldstein

series ordinal

2

1 reference

10 May 2018

Lauren B Gerson

series ordinal

3

1 reference

10 May 2018

language of work or name

English

0 references

publication date

29 March 2011

1 reference

10 May 2018

The American Journal of Gastroenterology

published in

1 reference

10 May 2018

volume

106

1 reference

10 May 2018

issue

8

1 reference

10 May 2018

page(s)

1439-1445

1 reference

10 May 2018

cites work

Eosinophilic esophagitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

GERD 2004: issues from the past and a consensus for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Effectiveness of proton pump inhibitors in nonerosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Patient-derived health state utilities for gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Eosinophilic esophagitis in adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Eosinophilic esophagitis: a 10-year experience in 381 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Clinical and Endoscopic Features of Eosinophilic Esophagitis in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Eosinophils in the esophagus--peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Pantoprazole on-demand effectively treats symptoms in patients with gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.94

21 January 2018

Identifiers

DOI

10.1038/AJG.2011.94

1 reference

10 May 2018

1 reference

10 May 2018